Abbott Laboratories buy Jefferies Financial Group Inc.
Start price
18.07.25
/
50%
€104.68
Target price
18.07.26
€124.73
Performance (%)
-12.69%
Price
20.03.26
€91.40
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -12.69%. This prediction currently runs until 18.07.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -3.413% | -3.413% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by Jefferies_Financial_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $145.00 price target on the stock, up previously from $143.00.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Jefferies_Financial_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€110.74
16.10.25
16.10.25
€127.63
16.10.26
16.10.26
-17.46%
20.03.26
20.03.26
